The PE News Headline

April 24, 2024

Category: GlaxoSmithKline

Buyout giants eye mammoth $54bn buyout of GlaxoSmithKline consumer unit: report

Mike Didymus
October 12, 2021

A string of private equity giants including Blackstone and Carlyle are reportedly circling GlaxoSmithKline’s consumer unit in a deal which could see it valued at up to £40bn. The post Buyout giants eye mammoth $54bn

Buyout

GlaxoSmithKline spinout SR One strikes $500m hard cap for debut independent fundraise

Mike Didymus
November 23, 2020

Transatlantic biotech investor SR One has raised its first fund in the wake of spinning out from pharmaceutical giant GlaxoSmithKline.

Appointments

Former UK accounting watchdog chairman Simon Dingeman joins Carlyle Group

Eric Johansson
June 15, 2020

Simon Dingemans has joined US private equity firm Carlyle Group as its managing director in charge of UK buyouts just months after he stepped down as chairman for the British Financial Reporting Council (FRC). Dingeman